索马托斯坦和阿尔茨海默病的病理生理学
1Institute of Psychiatry, Faculty of Medicine, University of São Paulo (USP), Brazil; Faculty of Languages, Federal University of Minas Gerais (UFMG), Brazil.
Ageing research reviews
|March 14, 2024
概括
阿尔茨海默病涉及改变的体静止素 (SST) 水平和神经元与粉样β斑块的相互作用. 这个模型将SST神经元功能障碍与疾病进展联系在一起,解释了关键的风险因素和认知缺陷.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 的特点是改变了体静止素 (SST) 水平和SST-阳性内部神经元 (SST-IN) 与粉样蛋白β (Aβ) 斑块的相互作用,导致神经元死亡.
- SST-IN在调节神经网络活动中起着至关重要的作用,并与AD病变发生有关.
研究的目的:
- 为阿尔茨海默病的发病过程提出一个分子模型,该模型的中心是体静止素内部神经元 (SST-IN) 的低功能和高活性.
- 阐明SST-IN功能障碍有助于Aβ产生,聚合和神经退行的机制.
主要方法:
- 理论审查和分子建模方法.
- 整合有关SST,Aβ,GABAB信号传递,MAPK通路和AD风险因素的现有研究.
主要成果:
- 假设低功能的和过度活跃的SST-INs通过GABAB抑制和APP处理驱动早期的轴突Aβ产生.
- 建议过度的SST-14释放形成粉样聚合物,与Aβ产生有毒的寡合体,导致SST-IN死亡并加剧斑块形成.
- 通过过度活跃的SST-INs进行的慢性SST2/4刺激与MAPK p38激活,体性p-tau和神经退行有关.
结论:
- 拟议的模型解释了AD的关键特征,包括Aβ斑块与SST-IN和过度活跃网络的重叠.
- 该模型解释了AD风险因素,如APOE4,性别差异和线粒体功能障碍.
- 它提供了关于AD相关认知障碍的见解,特别是在记忆领域,将它们与网络不稳定性和概括缺陷联系起来.
相关概念视频
Alzheimer's Disease: Overview
475
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
475
Alzheimer's Disease: Treatment
186
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
186
The Proteasome
8.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Gastritis-II: Pathophysiology
324
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
324
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
621
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
621
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541


